SEARCH RESULTS
300519 RESULTS
Andrew West
Puja Mehta
David Hart
Stratton VAMC United States
Cynthia Brown-Smith
United States
Bethany Dejoe
Member ASHAUnited States
Abraham Elterman
Independent researcher
Haakon Nygaard
University of British ColumbiaCanada
Toby Jarman
Bristol Medical schoolUnited Kingdom
Finally: Big Win on All Outcomes for Lecanemab in Phase 3 Topline Results
RESEARCH NEWS 2022-09-28 Research News Eisai and Biogen yesterday announced positive topline results from the Phase 3 Clarity trial of their anti-amyloid antibody lecanemab. The drug slowed decline on the primary endpoint, CDR-SB, by 27 percent over 18 months, and also nudged dow
Juan Vassallo
Columbia UniversityUnited States
austin momii
University of Colorado
Jane Burkett
United States
Sarah Alam
United States
Kelsey Campbell
Current Filters
No filters selected